Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson’s disease
Rob Powers, Maryam Etezadi‐Amoli, Edith M. Arnold, Sara Kianian, Irida Mance, Maxsim Gibiansky, Dan Trietsch, Alexander Alvarado, James D. Kretlow, Todd M. Herrington, Salima Brillman, Nengchun Huang, Peter Lin, Hung A. Pham, Adeeti V. Ullal
Abstract
< 0.001) during in-clinic tasks. MM4PD captured symptom changes in response to treatment that matched the clinician's expectations in 94% of evaluated subjects. In the remaining 6% of cases, symptom data from MM4PD identified opportunities to make improvements in pharmacologic strategy. These results demonstrate the promise of MM4PD as a tool to support patient-clinician communication, medication titration, and clinical trial design.
Topics & Concepts
SmartwatchParkinson's diseaseDyskinesiaInertial measurement unitDiseasePhysical medicine and rehabilitationMedicineNeuroscienceComputer scienceWearable computerEmbedded systemPsychologyArtificial intelligenceInternal medicineNeurological disorders and treatmentsParkinson's Disease Mechanisms and TreatmentsAdvanced Sensor and Energy Harvesting Materials